Ikarian Capital, LLC Anebulo Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 157,862 shares of ANEB stock, worth $205,220. This represents 0.05% of its overall portfolio holdings.
Number of Shares
157,862
Previous 157,862
-0.0%
Holding current value
$205,220
Previous $430,000
29.3%
% of portfolio
0.05%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.34MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$6.98 Million11.7% of portfolio
-
Lvw Advisors, LLC641KShares$833,3500.16% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$664,3940.06% of portfolio
-
Morgan Stanley New York, NY399KShares$518,9840.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA154KShares$200,2460.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $33.3M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...